Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.
|
This activity is supported by independent educational grants from Celgene Corporation, Lilly USA, Inc. and Novartis Pharmaceuticals.
|
You Are Invited to a LIVE CME/CPE/CNE Webcast Series:
Specialty Pharmacy Care and Cost Management Strategies for Psoriatic Disease Therapies
Live Webcast
Live Webcast Dates
| DAY |
DATE |
TIME |
| Tuesday |
August 20, 2019 |
12:30 PM - 2:00 PM ET |
| Thursday |
September 12, 2019 |
1:00 PM - 2:30 PM ET |
| Friday |
October 4, 2019 |
12:30 PM - 2:00 PM ET |
|
|
Michael Zeglinski, RPh
Senior Vice President, Specialty Pharmacy
OptumRx®/BriovaRx®
|
|
Robin Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
|
|
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
|
|
Paul Yamauchi, MD, PhD
Clinical Assistant Professor of Dermatology
David Geffen School of Medicine at UCLA
Adjunct Associate Professor
John Wayne Cancer Institute
|
|
TARGET AUDIENCE
|
- Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors and specialty pharmacists
- Pharmacy directors, registered nurses, quality directors, care managers, and other managed care and payer organization professionals
|
|
PROGRAM OVERVIEW
|
Psoriasis and psoriatic arthritis presents a significant clinical and humanistic burden to patients and payers. Fortunately, there has been a marked increase in the number of safe and effective therapies to the disease. As a result, payers, specialty pharmacists, and affiliated providers are challenged to match patients with the most appropriate therapeutic option. This program will focus on the therapeutic options available to manage the spectrum of pathologic challenges confronted by patients with psoriatic disease which can help enable specialty pharmacy professionals to improve patient quality of life and clinical outcomes.
|
|
EDUCATIONAL OBJECTIVES
|
After completing the activity, participants should be better able to:
- Explain the pathophysiology and immunologic pathways of psoriatic disease
- Align psoriatic disease specialty drug treatment algorithms with evidence-based treatment recommendations
- Utilize care pathways as cost management and appropriate use tools in psoriatic disease
- Employ specialty pharmacy and disease management services for psoriatic disease patients
|
|
AGENDA
|
Opening Comments/Overview
Michael Zeglinski, RPh
|
Current Evidence-Based Recommendations for the Treatment of Psoriasis
Alan Menter, MD / Paul Yamauchi, MD, PhD
|
Current Evidence-Based Recommendations for the Treatment of Psoriatic Arthritis
Robin Dore, MD
|
Specialty Pharmacy Management Opportunities for Psoriatic Disease
Michael Zeglinski, RPh
|
Audience Question and Answer Session
Key Takeaways and Closing Comments
|
|
|
ACCREDITATION INFORMATION
|
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0816-9999-19-135-L01-P
This activity is certified as Knowledge-based CPE.
|
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.
Fee Information
There is no fee for this educational activity.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
|
|
